EP3164114 - PURIFIED THERAPEUTIC NANOPARTICLES AND PREPARATION METHODS THEREOF [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 16.07.2021 Database last updated on 22.08.2024 | |
Former | The patent has been granted Status updated on 07.08.2020 | ||
Former | Grant of patent is intended Status updated on 11.05.2020 | ||
Former | Examination is in progress Status updated on 10.12.2019 | ||
Former | Request for examination was made Status updated on 07.04.2017 | ||
Former | The international publication has been made Status updated on 28.12.2016 | Most recent event Tooltip | 14.06.2024 | Lapse of the patent in a contracting state New state(s): TR | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. No. 226, Huanghe Street Shijiazhuang Hebei 050035 / CN | [2017/19] | Inventor(s) | 01 /
LI, Chunlei No.226 Huanghe Street Shijiazhuang Hebei 050035 / CN | 02 /
LI, Yanhui No.226 Huanghe Street Shijiazhuang Hebei 050035 / CN | 03 /
LIANG, Min No.226 Huanghe Street Shijiazhuang Hebei 050035 / CN | 04 /
WANG, Caixia No.226 Huanghe Street Shijiazhuang Hebei 050035 / CN | 05 /
WANG, Yajuan No.226 Huanghe Street Shijiazhuang Hebei 050035 / CN | 06 /
WANG, Shixia No.226 Huanghe Street Shijiazhuang Hebei 050035 / CN | 07 /
CHEN, Dongjian No.226 Huanghe Street Shijiazhuang Hebei 050035 / CN | 08 /
LI, Yongfeng No.226 Huanghe Street Shijiazhuang Hebei 050035 / CN | [2017/19] | Representative(s) | HGF HGF Limited 1 City Walk Leeds LS11 9DX / GB | [N/P] |
Former [2020/37] | HGF 1 City Walk Leeds LS11 9DX / GB | ||
Former [2017/19] | HGF Limited Delta House 50 West Nile Street Glasgow G1 2NP / GB | Application number, filing date | 15815596.0 | 03.07.2015 | [2017/19] | WO2015CN83255 | Priority number, date | CN201410314042 | 03.07.2014 Original published format: CN201410314042 | WO2014CN91277 | 17.11.2014 Original published format: PCT/CN2014/091277 | US201514790646 | 02.07.2015 Original published format: US201514790646 | [2017/19] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016000653 | Date: | 07.01.2016 | Language: | EN | [2016/01] | Type: | A1 Application with search report | No.: | EP3164114 | Date: | 10.05.2017 | Language: | EN | The application published by WIPO in one of the EPO official languages on 07.01.2016 takes the place of the publication of the European patent application. | [2017/19] | Type: | B1 Patent specification | No.: | EP3164114 | Date: | 09.09.2020 | Language: | EN | [2020/37] | Search report(s) | International search report - published on: | CN | 07.01.2016 | (Supplementary) European search report - dispatched on: | EP | 14.06.2017 | Classification | IPC: | A61K9/51, A61K31/337, A61K9/14, A61K9/19, A61K45/00, A61K47/42, A61P35/00 | [2017/28] | CPC: |
A61K9/5169 (EP,KR,US);
A61K31/337 (EP,KR,US);
A61K45/00 (RU);
A61K47/42 (RU);
A61K9/08 (KR);
A61K9/14 (RU);
|
Former IPC [2017/19] | A61K9/14, A61K9/19, A61K45/00, A61K47/42, A61P35/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2017/19] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | Title | German: | GEREINIGTE THERAPEUTISCHE NANOPARTIKEL UND HERSTELLUNGSVERFAHREN DAFÜR | [2017/19] | English: | PURIFIED THERAPEUTIC NANOPARTICLES AND PREPARATION METHODS THEREOF | [2017/19] | French: | NANOPARTICULES THÉRAPEUTIQUES PURIFIÉES ET LEURS PROCÉDÉS DE PRÉPARATION | [2017/19] | Entry into regional phase | 28.12.2016 | National basic fee paid | 28.12.2016 | Search fee paid | 28.12.2016 | Designation fee(s) paid | 28.12.2016 | Examination fee paid | Examination procedure | 15.01.2016 | Request for preliminary examination filed International Preliminary Examining Authority: CN | 28.12.2016 | Examination requested [2017/19] | 28.12.2016 | Date on which the examining division has become responsible | 05.01.2018 | Amendment by applicant (claims and/or description) | 13.12.2019 | Despatch of a communication from the examining division (Time limit: M03) | 18.02.2020 | Reply to a communication from the examining division | 12.05.2020 | Communication of intention to grant the patent | 28.07.2020 | Fee for grant paid | 28.07.2020 | Fee for publishing/printing paid | 28.07.2020 | Receipt of the translation of the claim(s) | Opposition(s) | 10.06.2021 | No opposition filed within time limit [2021/33] | Fees paid | Renewal fee | 29.07.2017 | Renewal fee patent year 03 | 30.07.2018 | Renewal fee patent year 04 | 26.07.2019 | Renewal fee patent year 05 | 23.07.2020 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 03.07.2015 | AL | 09.09.2020 | AT | 09.09.2020 | CY | 09.09.2020 | CZ | 09.09.2020 | DK | 09.09.2020 | EE | 09.09.2020 | HR | 09.09.2020 | LT | 09.09.2020 | LV | 09.09.2020 | MC | 09.09.2020 | MK | 09.09.2020 | NL | 09.09.2020 | PL | 09.09.2020 | RO | 09.09.2020 | RS | 09.09.2020 | SE | 09.09.2020 | SI | 09.09.2020 | SK | 09.09.2020 | SM | 09.09.2020 | TR | 09.09.2020 | BG | 09.12.2020 | NO | 09.12.2020 | GR | 10.12.2020 | IS | 09.01.2021 | PT | 11.01.2021 | [2024/29] |
Former [2024/22] | HU | 03.07.2015 | |
AL | 09.09.2020 | ||
AT | 09.09.2020 | ||
CY | 09.09.2020 | ||
CZ | 09.09.2020 | ||
DK | 09.09.2020 | ||
EE | 09.09.2020 | ||
HR | 09.09.2020 | ||
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
MC | 09.09.2020 | ||
MK | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RO | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
SI | 09.09.2020 | ||
SK | 09.09.2020 | ||
SM | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
IS | 09.01.2021 | ||
PT | 11.01.2021 | ||
Former [2023/30] | HU | 03.07.2015 | |
AL | 09.09.2020 | ||
AT | 09.09.2020 | ||
CY | 09.09.2020 | ||
CZ | 09.09.2020 | ||
DK | 09.09.2020 | ||
EE | 09.09.2020 | ||
HR | 09.09.2020 | ||
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
MC | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RO | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
SI | 09.09.2020 | ||
SK | 09.09.2020 | ||
SM | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
IS | 09.01.2021 | ||
PT | 11.01.2021 | ||
Former [2023/29] | HU | 03.07.2015 | |
AL | 09.09.2020 | ||
AT | 09.09.2020 | ||
CZ | 09.09.2020 | ||
DK | 09.09.2020 | ||
EE | 09.09.2020 | ||
HR | 09.09.2020 | ||
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
MC | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RO | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
SI | 09.09.2020 | ||
SK | 09.09.2020 | ||
SM | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
IS | 09.01.2021 | ||
PT | 11.01.2021 | ||
Former [2022/18] | AL | 09.09.2020 | |
AT | 09.09.2020 | ||
CZ | 09.09.2020 | ||
DK | 09.09.2020 | ||
EE | 09.09.2020 | ||
HR | 09.09.2020 | ||
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
MC | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RO | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
SI | 09.09.2020 | ||
SK | 09.09.2020 | ||
SM | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
IS | 09.01.2021 | ||
PT | 11.01.2021 | ||
Former [2021/37] | AL | 09.09.2020 | |
AT | 09.09.2020 | ||
CZ | 09.09.2020 | ||
DK | 09.09.2020 | ||
EE | 09.09.2020 | ||
HR | 09.09.2020 | ||
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RO | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
SI | 09.09.2020 | ||
SK | 09.09.2020 | ||
SM | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
IS | 09.01.2021 | ||
PT | 11.01.2021 | ||
Former [2021/36] | AL | 09.09.2020 | |
AT | 09.09.2020 | ||
CZ | 09.09.2020 | ||
EE | 09.09.2020 | ||
HR | 09.09.2020 | ||
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RO | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
SI | 09.09.2020 | ||
SK | 09.09.2020 | ||
SM | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
IS | 09.01.2021 | ||
PT | 11.01.2021 | ||
Former [2021/28] | AL | 09.09.2020 | |
AT | 09.09.2020 | ||
CZ | 09.09.2020 | ||
EE | 09.09.2020 | ||
HR | 09.09.2020 | ||
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RO | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
SK | 09.09.2020 | ||
SM | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
IS | 09.01.2021 | ||
PT | 11.01.2021 | ||
Former [2021/25] | AL | 09.09.2020 | |
AT | 09.09.2020 | ||
CZ | 09.09.2020 | ||
EE | 09.09.2020 | ||
HR | 09.09.2020 | ||
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RO | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
SM | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
IS | 09.01.2021 | ||
PT | 11.01.2021 | ||
Former [2021/24] | AT | 09.09.2020 | |
CZ | 09.09.2020 | ||
EE | 09.09.2020 | ||
HR | 09.09.2020 | ||
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RO | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
SM | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
PT | 11.01.2021 | ||
Former [2021/23] | CZ | 09.09.2020 | |
EE | 09.09.2020 | ||
HR | 09.09.2020 | ||
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RO | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
SM | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
PT | 11.01.2021 | ||
Former [2021/22] | CZ | 09.09.2020 | |
EE | 09.09.2020 | ||
HR | 09.09.2020 | ||
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RO | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
PT | 11.01.2021 | ||
Former [2021/21] | HR | 09.09.2020 | |
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
PT | 11.01.2021 | ||
Former [2021/18] | HR | 09.09.2020 | |
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
NL | 09.09.2020 | ||
PL | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
Former [2021/10] | HR | 09.09.2020 | |
LT | 09.09.2020 | ||
LV | 09.09.2020 | ||
PL | 09.09.2020 | ||
RS | 09.09.2020 | ||
SE | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
Former [2021/09] | LT | 09.09.2020 | |
SE | 09.09.2020 | ||
BG | 09.12.2020 | ||
NO | 09.12.2020 | ||
GR | 10.12.2020 | ||
Former [2021/07] | LT | 09.09.2020 | |
NO | 09.12.2020 | Documents cited: | Search | [A]WO2011057709 (MERCK PATENT GMBH [DE], et al) [A] 1-32 * page 22, lines 12-25 *; | [I]WO2011153010 (ABRAXIS BIOSCIENCES LLC [US], et al) [I] 1-32 * paragraphs [0277] , [0291] * * claims 1,21-23 *; | [I] - LI CHUNLEI ET AL, "Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: Is the crosslinked version more advantageous?", INTERNATIONAL JOURNAL OF PHARMACEUTICS, (201404), vol. 468, no. 1, doi:10.1016/J.IJPHARM.2014.04.010, ISSN 0378-5173, pages 15 - 25, XP029029801 [I] 1-32 * page 16, column 1, paragraph 6 - column 2, paragraph 2 * * page 18, column 2, paragraph 1 * DOI: http://dx.doi.org/10.1016/j.ijpharm.2014.04.010 | [XA] - STOLLENWERK M M ET AL, "Albumin-based nanoparticles as magnetic resonance contrast agents: I. Concept, first syntheses and characterisation", HISTOCHEMISTRY AND CELL BIOLOGY, SPRINGER, BERLIN, DE, (20100220), vol. 133, no. 4, ISSN 1432-119X, pages 375 - 404, XP019802809 [X] 1-3,12,14,17 * page 375, column 1, paragraph 1 * * page 380, column 1, paragraph 2 * * page 385 * [A] 4-11,13,15,16,18-32 | [A] - AHMED O ELZOGHBY ET AL, "Albumin-based nanoparticles as potential controlled release drug delivery systems", JOURNAL OF CONTROLLED RELEASE, ELSEVIER, AMSTERDAM, NL, vol. 157, no. 2, doi:10.1016/J.JCONREL.2011.07.031, ISSN 0168-3659, (20110720), pages 168 - 182, (20110801), XP028442118 [A] 1-32 * page 170, column 1, paragraph 3 * DOI: http://dx.doi.org/10.1016/j.jconrel.2011.07.031 | [A] - NEHAL IBRAHIM ET AL, "Albumin-bound nanoparticles of practically water-insoluble antimalarial lead greatly enhance its efficacy", INTERNATIONAL JOURNAL OF PHARMACEUTICS, (20140108), vol. 464, no. 1-2, doi:10.1016/j.ijpharm.2014.01.001, ISSN 0378-5173, pages 214 - 224, XP055108520 [A] 1-32 * page 215, column 2, paragraph 2 - page 216, column 1, paragraph 1 * * page 217, column 2, paragraph 2 - page 218, column 1, paragraph 2 * DOI: http://dx.doi.org/10.1016/j.ijpharm.2014.01.001 | International search | [Y]CN1736489 (ZHANG YANGDE [CN]) [Y] 19-29* Claim 1 *; | [Y]CN102988996 (UNIV TSINGHUA) [Y] 21-23, 25-29 * Claim 4 *; | [XY]CN103221042 (ABRAXIS BIOSCIENCE LLC) [X] 1-18, 32 * paragraphs [134], [138], [140] and [152]paragraphs [134], [138], [140] and [152] * [Y] 19-29 | by applicant | WO2011153010 | - LI CHUNLEI et al., "Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: Is the crosslinked version more advantageous?", International Journal of Pharmaceutics, (20140400), vol. 468, no. l, doi:10.1016/j.ijpharm.2014.04.010, pages 15 - 25, XP029029801 DOI: http://dx.doi.org/10.1016/j.ijpharm.2014.04.010 |